The global chloroform market size was valued at USD 8.12 billion in 2025 and is projected to grow from USD 8.27 billion in 2026 to USD 9.62 billion by 2034, registering a CAGR of 1.9% during the forecast period from 2026 to 2034. North America dominated the chloroform market with a market share of 36.5% in 2025.
Chloroform is a colorless, volatile organic compound with the chemical formula CHCl₃. It is widely used as an industrial solvent, chemical intermediate, and laboratory reagent in the production of pharmaceuticals, refrigerants, agrochemicals, and fluoropolymers. Although it was historically used as an anesthetic, its medical use has been discontinued due to safety concerns and potential health risks.
Download a Free Sample To learn more about this report,
Chloroform Use Is Shifting Toward Controlled Industrial Applications
The chloroform market trends show that health and environmental concerns are shifting chloroform use toward more controlled laboratory and industrial applications. This transition is increasing emphasis on exposure reduction, containment, and safer handling, while recent solvent-sustainability research identifies chloroform as a hazardous solvent requiring exposure to be minimized. The outcome is greater reliance on controlled-use environments and tighter solvent-management practices.
Deuterated Chloroform Is Sustaining Demand in NMR-Based Research
The use of deuterated chloroform is maintaining its role in analytical research as a solvent for proton NMR spectroscopy. This transition is supporting pharmaceutical and chemical characterization because chloroform-d provides suitable analyte solubility with relatively limited signal interference. The outcome is continued demand for high-purity chloroform-d across pharmaceutical, chemical, and academic laboratories.
Pharmaceutical Production and Expansion of Chemical Manufacturing Capacity Drive Market
Pharmaceutical production supports demand for chloroform as a solvent used in selected synthesis, extraction, and purification processes. Continued manufacturing of active pharmaceutical ingredients and specialty compounds creates recurring requirements for suitable solvent grades. This downstream consumption provides a steady demand base for chloroform suppliers.
Expansion of chemical manufacturing capacity strengthens the supply of chloroform by increasing production capabilities and improving availability for downstream users. Additional capacity can support more reliable procurement for pharmaceutical and specialty-chemical manufacturers while reducing supply constraints in regional markets. This stronger supply base enables chloroform producers to serve a wider range of industrial customers.
Health and Occupational Exposure Risks and Feedstock Price Fluctuations Restrain Chloroform Market Expansion
Health and occupational exposure risks increase the need for controlled handling, protective measures, and workplace safety procedures during chloroform production and use. These requirements can raise operating costs and discourage adoption in applications where safer substitutes are available, limiting market growth.
Feedstock price fluctuations create uncertainty in chloroform production costs and can place pressure on manufacturers' profit margins. Unpredictable input expenses can make pricing and supply planning more difficult, reducing producers' willingness to expand capacity and slowing market growth.
Chloroform Applications in Agrochemical Intermediates and Specialty Chemical Synthesis Create New Market Opportunities
Agrochemical intermediate manufacturers, specialty chemical producers, and chloromethane suppliers can benefit from chloroform-based chemistry used in selected pesticide and crop-protection synthesis routes. Companies such as SRF and Hari Orgochem can generate revenue through specialized intermediates, custom synthesis, and application-specific chemical products while supporting chloroform market growth.
Specialty chemical manufacturers and custom-synthesis providers can benefit from chloroform as a solvent or chemical input across selected organic synthesis applications beyond pharmaceutical production. Companies such as SRF and Nobian can capture value through specialized chemical intermediates, contract manufacturing, and integrated chloromethane portfolios, creating additional commercial opportunities.
Concentrated Production Capacity and Cross-Border Trade Disruptions Hinder Chloroform Market Growth
Chloroform production is concentrated among integrated chloromethane producers, making regional supply more dependent on the operating rates and capacity decisions of a limited number of manufacturers. This concentration can create supply imbalances when major plants undergo maintenance, capacity changes, or unplanned disruptions, making it harder for downstream users to maintain consistent sourcing.
Cross-border trade disruptions can affect the movement of chloroform through changes in freight availability, shipping costs, tariffs, and geopolitical conditions. These disruptions can delay deliveries and complicate international supply planning, particularly for markets that depend on imported material. In 2025, disruptions across global shipping routes and higher freight costs continued to affect chemical supply chains, increasing uncertainty for internationally traded chemical products.
The technical segment accounted for a share of 46.8% in 2025, supported by its established use across industrial and commercial applications. The fluorocarbon segment serves applications requiring specialized performance, while the alcohol stabilized segment supports uses requiring improved product stability.
The fluorocarbon segment is expected to grow at a CAGR of 5.21% during the forecast period 2026-2034, driven by increasing demand for specialized fluorocarbon-based applications. The technical segment continues to benefit from established industrial use, while the alcohol stabilized segment supports applications requiring stabilized formulations.
Request Customizationto receive a tailored report.
The solvent segment accounted for a share of 31.6% in 2025, owing to its broad use in chemical processing and formulation activities. The intermediate segment supports chemical synthesis, while the refrigerant segment serves cooling applications. The reagent segment is used in analytical and laboratory processes.
The refrigerant segment is expected to grow at a CAGR of 5.36% during the forecast period 2026-2034, fueled by increasing demand for cooling and refrigeration applications. The intermediate segment supports chemical production, while the solvent and reagent segments continue to serve processing and analytical requirements.
The chemical segment accounted for a share of 38.7% in 2025, due to its extensive use across chemical processing and manufacturing activities. The pharmaceutical segment supports drug production and formulation, while the automobile segment serves automotive-related applications. The food and beverages segment uses the product in specialized processing requirements.
The pharmaceutical segment is expected to grow at a CAGR of 5.14% during the forecast period 2026-2034, propelled by increasing demand for pharmaceutical manufacturing and formulation applications. The chemical segment continues to support industrial processing, while the automobile and food and beverages segments maintain demand through their respective end-use applications.
Speak to an Analystto discuss market opportunities.
The North America chloroform market accounted for the largest regional share of 36.5% in 2025, driven by established pharmaceutical and chemical manufacturing, continued use of chloroform as a solvent and chemical intermediate, and demand from industrial and laboratory applications. The U.S. chloroform market is supported by the U.S. Bureau of Labor Statistics’ projection that pharmaceutical and medicine manufacturing employment will increase by 5% from 2024 to 2034, reaching 369,500 jobs, while scientific research and development employment is projected to grow 8.7% over the same period, supporting future demand for chloroform in pharmaceutical, laboratory, and chemical applications.
The Canada chloroform market is fuelled by Canada’s pharmaceutical R&D sector, where Statistics Canada reported 9,267 R&D FTEs in 2023 and a 19.8% increase in researchers and research managers, while the broader pharmaceutical sector remained heavily focused on medical and health sciences, supporting future demand for chloroform in pharmaceutical and laboratory applications.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific chloroform market is expected to grow at a CAGR of 5.68% during the forecast period 2026-2034, showcasing the fastest-growing regional market, propelled by expanding pharmaceutical and chemical manufacturing, rising demand for solvents and chemical intermediates, and increasing industrial applications across the region. The Japan chloroform market is supported by Japan’s biopharmaceutical and regenerative medicine industries, with the domestic market for these industries targeted to exceed JPY 3.3 trillion by 2030, while the regenerative medicine and gene therapy market is projected to reach about JPY 1.08 trillion by 2035, supporting future demand for chloroform in pharmaceutical and laboratory applications.
The China chloroform market is driven by the country’s pharmaceutical industry, with China’s Ministry of Industry and Information Technology targeting revenue of more than CNY 3.5 trillion for above-scale pharmaceutical manufacturing enterprises by 2030, while annual growth of the innovative-drug industry is targeted at more than 20%, supporting future demand for chloroform in pharmaceutical and chemical applications.
The Europe chloroform market accounted for a 25.4% share and is expected to grow at a CAGR of 4.41% during the forecast period 2026-2034, fuelled by established pharmaceutical and chemical industries, continued demand for solvents and chemical intermediates, and stringent industrial and environmental regulations across the region. The U.K. chloroform market is propelled by the government’s projection that life sciences priority occupations will increase by 44% between 2025 and 2035, adding around 66,000 jobs, while the UK Life Sciences Sector Plan targets greater investment in commercial R&D by 2030, supporting future demand for chloroform in pharmaceutical, laboratory, and research applications.
The Germany chloroform market is supported by the government’s plan to strengthen Germany as a global chemical, pharmaceutical, and biotechnology hub through the Chemieagenda 2045 and continued pharmaceutical-sector measures, alongside the country’s pharmaceutical industry investing more than €8 billion annually in R&D, supporting future demand for chloroform in pharmaceutical and chemical applications.
The chloroform market competitive landscape is moderately consolidated, with competition comprising integrated chemical manufacturers, chlor-alkali producers, specialty chemical suppliers, and regional chloroform manufacturers. Key players such as BASF SE, Solvay S.A., Dow Chemical Company, INEOS, and Olin Corporation collectively are estimated to account for approximately 45–50% of the global chloroform market share.
Established players compete primarily on production capacity, product purity, feedstock integration, and supply reliability. Emerging and regional players in the chloroform market ecosystem compete through specialized grades, application-specific formulations, regional distribution networks, and customized supply solutions.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Head
Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.
His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.
Chlor-Alkali Chemical Market Size, Share, Growth, Analysis, 2034
Ammonia Market Size, Share, Growth, Analysis, Report, 2034
Chlorine Market Size, Share, Growth, Analysis, Report, 2034
Caustic Soda Market Size, Share, Growth, Analysis, Report, 2034
Ammonium Nitrate Market Size, Share, Growth, Forecast, 2034
Ammonium Hydroxide Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com